Optimizing Testosterone is NOT One-Size-Fits-All (TRT, HCG, Enclomiphene, & MORE)

24 Mar 2026 · 14 min
14:15

In this educational video Dr. Ashley Frazee explains why testosterone optimization requires individualized treatment rather than a single “one‑size‑fits‑all” approach. She begins with a factory‑warehouse analogy to illustrate the hypothalamic‑pituitary‑testicular (HPT) axis, describing how the hypothalamus (board of directors) releases GnRH, the pituitary (floor manager) issues LH and FSH, and the testes (factory floor) produce testosterone and sperm. She stresses that patients fall into two broad diagnostic categories – low LH/FSH (a “lazy manager”) or high LH/FSH with low testosterone (a “tired factory”). Accurate blood work, which she recommends via the at‑home Rhythm kit, is essential to identify the category. She then reviews the major therapeutic options: • Testosterone Replacement Therapy (TRT) – direct testosterone delivery that quickly restores levels but suppresses endogenous LH/FSH, can shrink testicles, and may reduce sperm in 60‑70% of men (though not a reliable birth‑control method). • Human Chorionic Gonadotropin (HCG) – an LH‑mimetic that binds testicular LH receptors, has a long half‑life, supports intratesticular testosterone and sperm production, and can be used as an “insurance” when on TRT. Downsides include cost and injection burden. • Gonadotropin (Gonadorelin) – a synthetic GnRH that stimulates the pituitary to release LH and FSH upstream. It has a very short half‑life (~10 min) requiring frequent dosing or a pump; still, some patients achieve substantial testosterone gains. • Clomiphene/Enclomiphene (Clomid) – oral selective estrogen receptor modulators. Enclomiphene blocks brain estrogen receptors, prompting a surge in LH/FSH and testosterone; however, the accompanying zyclomiphene component has a long half‑life and can cause estrogen‑related brain fog. Dosing must balance testosterone rise with mood/cognitive side‑effects. • Kisspeptin – a peptide that activates hypothalamic GnRH release, effectively “jump‑starting” the HPT axis. It may boost libido but is difficult to dose and monitor, making it a niche, precision tool. Throughout, Dr. Frazee highlights practical considerations (injection frequency, cost, side‑effects, impact on fertility) and encourages viewers to match therapy to their physiological profile and personal goals. She also promotes the Rhythm at‑home lab service for convenient, comprehensive hormone panels. The video concludes with a call to empower patients to act as the “CEO” of their bodies, choose wisely, and seek personalized care.

Chapters

More from Ashley

15:48
youtube.com

I Ranked Every Way to Lose Visceral Fat — Here's What Actually Works

today
16:21
youtube.com

Your Mitochondria Can Reset - Here’s How

1w ago
0:25
youtube.com

ARA-290: Nerve Pain & Healing Peptide Discovery

1w ago
0:22
youtube.com

Fixing Mitochondria: The TRUTH About SS-31 Peptide

1w ago
18:16
youtube.com

This ONE Blood Test Detects Inflammation Inside You

2w ago
18:10
youtube.com

I Bought Peptides from China

2w ago
1:57
youtube.com

The Social Biological Emergency That Leads to Cortisol Resistance

3w ago
13:27
youtube.com

I Investigated How to Actually Live Longer. We're Missing Something BIG

3w ago
1:01
youtube.com

Mots-C: Pre-workout peptide or just Animal Science?

1mo ago
1:37
youtube.com

The Truth About 5-Amino-1MQ: The Controversial Fat Loss Molecule

1mo ago
1:13
youtube.com

The TRUTH About AOD9604: Fat Loss Hype vs. Reality

1mo ago
See all content